ReviewCurrent HIV/AIDS reports2026
Central Nervous System HIV Persistence and Clinical Consequences During Suppressive ART.
Review in Current HIV/AIDS reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThis review discusses recent advances in understanding the mechanisms of CNS HIV invasion and persistence and examines how these processes relate to the neurologic complications of HIV. RECENT
findingsRecent studies have provided compelling evidence that HIV can persist within CNS macrophages and microglia despite long-term suppressive ART, supporting the existence of a CNS reservoir. Updates to treatment of neurosymptomatic CSF HIV RNA escape include evaluation of CNS-specific drug resistance patterns and ART optimization. Evaluation of cognitive symtpoms in persons with HIV should include a comprehensive medical and neurologic evaluation, cessation of Efavirenz, and evaluation of HIV disease activity and immune dysregulation. Novel HIV cure strategies, including shock-and-kill approaches, block-and-lock strategies, and broadly neutralizing antibodies have highlighted the importance of understanding CNS reservoir dynamics and potential neurotoxicity when designing HIV cure strategies. HIV enters the CNS during early infection and may establish a persistent viral reservoir. CNS HIV persistence has important clinical implications, including symptomatic CSF HIV RNA escape and cognitive dysfunction, and may represent a barrier to HIV cure.
Indexed as
Identifiers
42223553What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.